CADL

Candel Therapeutics Inc. is a pioneering biotechnology company leveraging oncolytic virus technology to develop localized cancer therapies that target malignant cells while preserving healthy tissue. With a strong emphasis on enhancing anti-tumor immunity, Candel's diverse and innovative pipeline addresses the treatment challenges posed by various difficult-to-treat malignancies. Supported by a solid intellectual property portfolio and strategic partnerships with leading research institutions, Candel is strategically positioned to make significant advancements in oncology, aiming to transform cancer care and improve patient outcomes.